2′-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model

A nanoparticle (NP) formulation with 2′-(2-bromohexadecanoyl)-paclitaxel (Br-16-PX) conjugate was developed in these studies for the treatment of non-small cell lung cancer (NSCLC). The lipophilic paclitaxel conjugate Br-C16-PX was synthesized and incorporated into lipid NPs where the 16-carbon chai...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lei, Schorzman, Allison N, Ma, Ping, Madden, Andrew J, Zamboni, William C, Benhabbour, Soumya Rahima, Mumper, Russell J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124067/
https://www.ncbi.nlm.nih.gov/pubmed/25114529
http://dx.doi.org/10.2147/IJN.S66040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124067/
https://www.ncbi.nlm.nih.gov/pubmed/25114529
http://dx.doi.org/10.2147/IJN.S66040

Ejemplares similares